Fulcrum Therapeutics, Inc.
USD3.62
-0.03 (-0.82%)
CEO
Alexander C. Sapir
IPO Date
2019-07-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.74
Prev. Close
$3.65
Day Low
$3.58
Day High
$3.74
52W Low
$2.83
52W High
$15.74
Market Cap
$0.20B
Volume
0.80M
| 53,651 |
| $3.56 |
| 15 Jul 2026 | TANG KEVIN | 10 percent owner | P-Purchase | Acquired | 75,952 | $3.58 |
| 15 Jul 2026 | TANG KEVIN | 10 percent owner | P-Purchase | Acquired | 107,377 | $3.56 |
| 15 Jul 2026 | TANG KEVIN | 10 percent owner | Disposed | 0 | $0.00 |
| 2 Jul 2026 | Banks Sonja | director | A-Award | Acquired | 32,000 | $3.66 |
| 2 Jul 2026 | Dorton Katina | director | A-Award | Acquired | 32,000 | $3.66 |
| 2 Jul 2026 | Gould Robert J | director | A-Award | Acquired | 32,000 | $3.66 |
| 2 Jul 2026 | Haviland Kate | director | A-Award | Acquired | 32,000 | $3.66 |
| 2 Jul 2026 | King Rachel K. | director | A-Award | Acquired | 32,000 | $3.66 |